In DCCC's third application round, two new initiatives have received support. Photo: DCCC/Canva.
11-10-2023
A new national initiative will develop guidelines for research on social inequality, while a new national hematological research network aims to enhance collaboration within the unique field.
Two new initiatives have received support from DCCC in the third application round of 2023. Both initiatives have the potential to ensure a high and consistent quality in Danish cancer research and treatment and will contribute to DCCC's vision.
Learn more about the supported initiatives below. The next application round is open and will run until November 14, 2023, at 15:00 - Read more by clicking here (in Danish).
SEPLINE: A national initiative for knowledge sharing and development of guidelines for research in social inequality in cancer
Social inequality in cancer is a major health policy and clinical focus area. However, knowledge of inequality across different types of cancers and over time is limited due to significant variation in the way inequality is measured and analyzed at different institutions. These divergent approaches across different types of cancer and institutions increase the risk of misinterpretations with potentially serious consequences in the treatment of cancer patients.
Hence, the applicants aim to establish a national interdisciplinary initiative to enhance comparability and usability of research findings from various institutions, reduce the risk of misinterpretations, and facilitate assessments of inequality in cancer care.
The initiative plans to host two workshops where participants will create specific recommendations. These recommendations will subsequently undergo pilot testing using data from various patient groups. Finally, the insights will be summarized into a user-friendly, shared national guideline on how to assess inequality in cancer care.
The target audience for these workshops includes healthcare researchers and health economists from universities across Denmark, hospitals, DMCGs, and interest organizations, as well as experts from relevant institutions such as the Danish Health Authority, the Danish Health Data Authority, Statistics Denmark, and the Danish National Clinical Registries (RKKP).
National Interdisciplinary Hematological Research Network Hematology is a specialty with unique challenges for patients, families, and healthcare professionals due to complex care and treatment pathways with acute, persistent and burdensome symptoms, complications and late effects. Addressing these challenges requires a collective effort.
Interdisciplinary health research is experiencing significant growth but is primarily conducted at individual hospitals. A national interdisciplinary research network is an initiative where strategic efforts can be coordinated, and the establishment of research activities can be ensured both nationally and internationally.
Specifically, the network plans to hold four meetings annually, with two of them taking place virtually. The purpose of these meetings is to address key clinical and research issues across the hospitals in Denmark. Consequently, the network aims to strengthen hematological research by promoting collaboration among researchers with diverse healthcare backgrounds. The network will serve as a platform for idea generation, knowledge sharing, the establishment of national projects and databases, as well as the collective implementation of research findings into practice.